{"title":"IgG4相关腹膜后纤维化需要综合治疗和长期定期复查","authors":"K. Clark, Ali SM Jawad","doi":"10.1002/tre.949","DOIUrl":null,"url":null,"abstract":"IgG4‐related retroperitoneal fibrosis is rare but eminently treatable. Here the authors discuss recently published classification criteria and how the disease is managed, including maintenance therapy once patients are in remission.","PeriodicalId":509037,"journal":{"name":"Trends in Urology & Men's Health","volume":"43 49","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"IgG4‐related retroperitoneal fibrosis needs comprehensive treatment and regular long‐term review\",\"authors\":\"K. Clark, Ali SM Jawad\",\"doi\":\"10.1002/tre.949\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"IgG4‐related retroperitoneal fibrosis is rare but eminently treatable. Here the authors discuss recently published classification criteria and how the disease is managed, including maintenance therapy once patients are in remission.\",\"PeriodicalId\":509037,\"journal\":{\"name\":\"Trends in Urology & Men's Health\",\"volume\":\"43 49\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Trends in Urology & Men's Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/tre.949\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trends in Urology & Men's Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/tre.949","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
IgG4‐related retroperitoneal fibrosis needs comprehensive treatment and regular long‐term review
IgG4‐related retroperitoneal fibrosis is rare but eminently treatable. Here the authors discuss recently published classification criteria and how the disease is managed, including maintenance therapy once patients are in remission.